These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12530556)
41. Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels. Alaupovic P; Heinonen T; Shurzinske L; Black DM Atherosclerosis; 1997 Aug; 133(1):123-33. PubMed ID: 9258416 [TBL] [Abstract][Full Text] [Related]
42. Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins. Brewer HB Klin Wochenschr; 1981 Sep; 59(18):1023-35. PubMed ID: 7029129 [TBL] [Abstract][Full Text] [Related]
43. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus. Waysbort J; Regitz G; Brunner D Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618 [TBL] [Abstract][Full Text] [Related]
44. Effects of Mediterranean diet on lipid levels and cardiovascular risk in renal transplant recipients. Barbagallo CM; Cefalù AB; Gallo S; Rizzo M; Noto D; Cavera G; Rao Camemi A; Marino G; Caldarella R; Notarbartolo A; Averna MR Nephron; 1999; 82(3):199-204. PubMed ID: 10395991 [TBL] [Abstract][Full Text] [Related]
45. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation. Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906 [TBL] [Abstract][Full Text] [Related]
46. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290 [TBL] [Abstract][Full Text] [Related]
47. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
48. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase. Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098 [TBL] [Abstract][Full Text] [Related]
49. Alterations in plasma lipoproteins and apolipoproteins associated with estrogen-induced hyperlipidemia in the laying hen. Hermier D; Forgez P; Williams J; Chapman MJ Eur J Biochem; 1989 Sep; 184(1):109-18. PubMed ID: 2776762 [TBL] [Abstract][Full Text] [Related]
50. Influence of probucol administration on lipoprotein cholesterol and apolipoproteins in normolipemic males. Berg A; Frey I; Baumstark M; Keul J Atherosclerosis; 1988 Jul; 72(1):49-54. PubMed ID: 3214458 [TBL] [Abstract][Full Text] [Related]
51. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia. Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691 [TBL] [Abstract][Full Text] [Related]
52. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins. Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138 [TBL] [Abstract][Full Text] [Related]
53. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait. Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883 [TBL] [Abstract][Full Text] [Related]
54. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels. Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494 [TBL] [Abstract][Full Text] [Related]
55. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530 [TBL] [Abstract][Full Text] [Related]
56. Transfer of apolipoproteins between plasma lipoproteins and exogenous lipid particles after repeated bolus injections or during a continuous infusion of fat emulsion. Tonouchi H; Iriyama K; Carpentier YA JPEN J Parenter Enteral Nutr; 1990; 14(4):381-5. PubMed ID: 2119445 [TBL] [Abstract][Full Text] [Related]
57. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study. Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402 [TBL] [Abstract][Full Text] [Related]
58. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
59. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587 [TBL] [Abstract][Full Text] [Related]